Adalimumab-Fkjp

Common brands: Humira, Adalimumab, Methotrexate, Trexall, Otrexup

Top reporter: Biocon Biologics Inc

Tumor Necrosis Factor Blocker [EPC]Folate Analog Metabolic Inhibitor [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Aminosalicylate [EPC]
43,783
Total Reports
32,169
Serious Reports
6,362
Death Reports
30
Reported Reactions
Death Report Ratio: High (14.53%)

Patient Demographics

Male
10,862
Female
22,271

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Adalimumab-Fkjp.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 10,344
8.1%
2 OFF LABEL USE 8,229
6.4%
3 RHEUMATOID ARTHRITIS 5,591
4.4%
4 PAIN 5,335
4.2%
5 FATIGUE 5,294
4.1%
6 ARTHRALGIA 5,056
3.9%
7 RASH 4,502
3.5%
8 CONDITION AGGRAVATED 4,300
3.4%
9 DRUG INTOLERANCE 4,164
3.2%
10 SYSTEMIC LUPUS ERYTHEMATOSUS 4,006
3.1%
11 DIARRHOEA 3,953
3.1%
12 NAUSEA 3,941
3.1%
13 JOINT SWELLING 3,936
3.1%
14 HEADACHE 3,894
3.0%
15 ALOPECIA 3,793
3.0%
16 TREATMENT FAILURE 3,757
2.9%
17 ABDOMINAL DISCOMFORT 3,756
2.9%
18 SYNOVITIS 3,755
2.9%
19 PSORIATIC ARTHROPATHY 3,652
2.8%
20 ARTHROPATHY 3,572
2.8%
21 GLOSSODYNIA 3,554
2.8%
22 PEMPHIGUS 3,453
2.7%
23 INFUSION RELATED REACTION 3,433
2.7%
24 MALAISE 3,420
2.7%
25 SWELLING 3,346
2.6%
26 HAND DEFORMITY 3,305
2.6%
27 GENERAL PHYSICAL HEALTH DETERIORATION 3,276
2.6%
28 HYPERSENSITIVITY 3,216
2.5%
29 VOMITING 3,209
2.5%
30 CONTRAINDICATED PRODUCT ADMINISTERED 3,204
2.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.